Literature DB >> 7639323

Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.

T Wisniewski1, A A Golabek, E Kida, K E Wisniewski, B Frangione.   

Abstract

Several apolipoproteins are known to be closely associated with amyloid fibrillogenesis. Serum amyloid A, apolipoprotein (apo) AII and apo A1 are each deposited as biochemically distinct forms of amyloid. Late-onset Alzheimer's disease is linked to one isotype of apo E, apo E4. Apo E and apo E4 in particular have been shown to modulate amyloid fibril formation by amyloid-beta peptides in vitro. Furthermore, the carboxy terminus of apo E has been shown to be a constituent of plaque amyloid. We show immunohistochemically and electron microscopically the presence of apo A1 in senile plaques. The intact apo A1 can itself form amyloid-like fibrils in vitro that are Congo Red positive. We propose that some proteins when misfolded can propagate this misfolding to identical units, either autocatalytically or to other proteins that are induced to fold into the same abnormal conformation. This conformational mimicry may initiate and/or augment fibrillogenesis in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639323      PMCID: PMC1869828     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  SP-40,40 is a constituent of Alzheimer's amyloid.

Authors:  N H Choi-Miura; Y Ihara; K Fukuchi; M Takeda; Y Nakano; T Tobe; M Tomita
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.

Authors:  W C Nichols; R E Gregg; H B Brewer; M D Benson
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.

Authors:  A von Eckardstein; H Funke; M Walter; K Altland; A Benninghoven; G Assmann
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

4.  Differences between vascular and plaque core amyloid in Alzheimer's disease.

Authors:  F Prelli; E Castaño; G G Glenner; B Frangione
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

5.  Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease.

Authors:  D J Selkoe; C R Abraham; M B Podlisny; L K Duffy
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

6.  Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease.

Authors:  C Soto; B Frangione
Journal:  Neurosci Lett       Date:  1995-02-17       Impact factor: 3.046

7.  Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

Authors:  T Wisniewski; B Frangione
Journal:  Neurosci Lett       Date:  1992-02-03       Impact factor: 3.046

8.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

Authors:  Y Namba; M Tomonaga; H Kawasaki; E Otomo; K Ikeda
Journal:  Brain Res       Date:  1991-02-08       Impact factor: 3.252

9.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

10.  Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma.

Authors:  D E Jenne; B Lowin; M C Peitsch; A Böttcher; G Schmitz; J Tschopp
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

View more
  30 in total

1.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

2.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

Review 3.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

Review 4.  Murine models of Alzheimer's disease and their use in developing immunotherapies.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Biochim Biophys Acta       Date:  2010-05-13

5.  Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.

Authors:  K Nishida; A J Quantock; A Dota; N H Choi-Miura; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 6.  Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration.

Authors:  Jeriel T R Keeney; Aaron M Swomley; Sarah Förster; Jessica L Harris; Rukhsana Sultana; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

Review 7.  Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Authors:  Thomas Wisniewski; Allal Boutajangout
Journal:  Brain Struct Funct       Date:  2009-12-10       Impact factor: 3.270

8.  Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Authors:  Alex E Roher; Chera L Maarouf; Lucia I Sue; Yiran Hu; Jeffrey Wilson; Thomas G Beach
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

Review 9.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

10.  Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E.

Authors:  Claudine Neyen; Annette Plüddemann; Pietro Roversi; Benjamin Thomas; Lei Cai; Deneys R van der Westhuyzen; Robert B Sim; Siamon Gordon
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.